Yuichi Uwai

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 10

Top Topics

Atomic Force Microscopy

Electronic Health Record

Top Venues

Drugs - real world outcomes

Biopharmaceutics & drug disposition

Congenital anomalies

This page only lists publications with an associated author ORCID identifier.

Publications

Yuichi Uwai, Tomohiro Nabekura
Relationship Between Clozapine and Non-Hematological Malignant Tumors: A Pharmacovigilance Analysis Using the FDA Adverse Event Reporting System Database. Drugs - real world outcomes 11 (2) (2024)
Yuichi Uwai, Tomohiro Nabekura
Relationship Between Clozapine and Non-Hematological Malignant Tumors: A Pharmacovigilance Analysis Using the FDA Adverse Event Reporting System Database. Drugs - real world outcomes 11 (2) (2024)
Yuichi Uwai, Tomohiro Nabekura
Relationship Between Clozapine and Non-Hematological Malignant Tumors: A Pharmacovigilance Analysis Using the FDA Adverse Event Reporting System Database. Drugs - real world outcomes (2024)
Yuichi Uwai, Tomohiro Nabekura
A safety signal for congenital strabismus associated with valproic acid: A pharmacovigilance analysis utilizing the FDA Adverse Event Reporting System database. Congenital anomalies (2024)
Yuichi Uwai, Tomohiro Nabekura
A safety signal for congenital strabismus associated with valproic acid: A pharmacovigilance analysis utilizing the FDA Adverse Event Reporting System database. Congenital anomalies 64 (5) (2024)
Yuichi Uwai, Tomohiro Nabekura
Relationship Between Clozapine and Non-Hematological Malignant Tumors: A Pharmacovigilance Analysis Using the FDA Adverse Event Reporting System Database. Drugs - real world outcomes 11 (2) (2024)
Yuichi Uwai, Tomohiro Nabekura
Data Mining for Risks of Clozapine Side Effects, Including Neutropenia, Associated with Lithium Carbonate Administration: Analysis Using the Japanese Adverse Drug Event Report Database. Drugs - real world outcomes (2023)
Yuichi Uwai, Takato Suzuki, Ryota Kondo, Tatsuya Kawasaki, Tomohiro Nabekura
Effect of renal ischemia on urinary excretion of lithium in rats. Biopharmaceutics & drug disposition 39 (9) (2019)
Yuichi Uwai, Tatsuya Kawasaki, Tomohiro Nabekura
Nonlinear disposition of lithium in rats and saturation of its tubular reabsorption by the sodium-phosphate cotransporter as a cause. Biopharmaceutics & drug disposition 39 (2) (2018)
Yuichi Uwai, Tatsuya Kawasaki, Tomohiro Nabekura
D-Malate decreases renal content of α-ketoglutarate, a driving force of organic anion transporters OAT1 and OAT3, resulting in inhibited tubular secretion of phenolsulfonphthalein, in rats. Biopharmaceutics & drug disposition 38 (8) (2017)